UNSPSC 85515736: Supplement right foot artery with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right foot artery with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04UV37Z

UNSPSC 85515736 Supplement right foot artery with autologous tissue substitute, percutaneous approach is a Commodity code that shows no relevant recent state and local procurement activity. The six recent opportunities tagged under this code — independent medical evaluation services for pension disability determinations, surgical carve-out benefits management, occupational medical surveillance, emergency medical services for detained youth, pharmacy benefit management, and temporary health professional staffing — are administrative and operational healthcare services wholly unrelated to vascular surgical procedures or tissue-substitute implantation. None of these solicitations contemplate procurement of medical devices, surgical supplies, procedural services aligned with the code's clinical descriptor, or the specialized interventional cardiology or vascular surgery capability the code nominal scope implies. The mismatch between code and opportunity content suggests either systematic mis-tagging by the issuing bodies or use of the UNSPSC hierarchy as a placeholder category during initial procurement setup rather than a true reflection of the work being bought.

Activity appears confined to administrative health plan and staffing management across Arizona, California, Florida, and Washington state jurisdictions—county health systems, county pension boards, municipal retirement offices, and state transportation agencies—none of which are purchasing vascular surgery or tissue-substitute services under this code. Absent evidence of substantive procurement aligned with the code's stated clinical domain, this code does not represent a meaningful business development opportunity in state and local contracting at this time.